Schedule 13D ownership disclosure
CARTESIAN THERAPEUTICS INC
Security class unavailable · CUSIP: 816212104
Event date: 2019-11-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,879,064
- Percent of class
- 5.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-19-000806
- Form type
- SC 13D
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Nov 13, 2019
- Reporting period
- Nov 08, 2019
- Description
- Schedule 13D beneficial ownership